Estimated read time: Less than a minute
TRENTON, N.J. (AP) — New Jersey will receive more than $500,000 as part of a nationwide settlement with a drugmaker over allegations that the company improperly promoted medications including the attention deficit disorder drugs Adderall XR.
Acting Attorney General John Hoffman announced the settlement with Shire Specialty Pharmaceuticals Friday.
The company was accused of unlawfully marketing and promoting Adderall and four other drugs for uses not approved by the Food and Drug Administration. The company also was accused of making claims about the drugs' effectiveness that weren't supported by clinical evidence.
Shire Specialty Pharmaceuticals is based in Wayne, Pennsylvania and is a division of United Kingdom-based Shire Pharmaceuticals.
The company will pay a total of $56.5 million to the participating states and the federal government.